Fladrafinil (CRL-40,941) is metabolized in the body into modafinil, the FDA-approved wakefulness-promoting drug — but fladrafinil itself is an unapproved research chemical with no dedicated human trials of its own. Its effects are presumed to overlap with modafinil's well-established profile because of this metabolic relationship, but that's an inference, not a direct finding about fladrafinil itself.
Both part of the modafinil family of wakefulness compounds, positioned differently. Fladrafinil is generally described as notably more potent than adrafinil (modafinil's prodrug), while Hydrafinil is actually a metabolite of modafinil itself — your body would produce some of it naturally if you took modafinil.
Less human safety data, mainly — modafinil has decades of prescription use and monitoring behind it; Fladrafinil is far newer to the research space with a much thinner evidence base, even with closely related chemistry.
Looking for something specific, or placing a wholesale order? Send us a DM or email.